Galmed Pharma (GLMD) Tops Q2 EPS by 4c
Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.